[Exosomal FZD10 derived from non-small cell lung cancer cells promotes angiogenesis of human umbilical venous endothelial cells in vitro]

Nan Fang Yi Ke Da Xue Xue Bao. 2022 Sep 20;42(9):1351-1358. doi: 10.12122/j.issn.1673-4254.2022.09.11.
[Article in Chinese]

Abstract

Objective: To investigate the effect of exosomal FZD10 derived from non-small cell lung cancer (NSCLC) cells on angiogenesis of human umbilical venous endothelial cells (HUVECs) and explore the possible mechanism.

Methods: We analyzed the expression of FZD10 in two NSCLC cell lines (95D and H1299 cells), normal human bronchial epithelial cells (BEAS-2B cells) and their exosomes isolated by ultracentrifugation. Cultured HUVECs were treated with the exosomes derived from NSCLC cells or NSCLC cells transfected with FZD10-siRNA, and the changes in tube formation ability of the cells were analyzed using an in vitro angiogenesis assay. ELISA was performed to determine the concentration of VEGFA and Ang-1 in the conditioned media of HUVECs, and RT-qPCR was used to analyze the mRNA levels of VEGFA and Ang-1 in the HUVECs. The effects of exosomal FZD10 on the activation of PI3K, Erk1/2 and YAP/TAZ signaling pathways were evaluated using Western blotting.

Results: Compared with BEAS-2B cells and their exosomes, 95D and H1299 cells and their exosomes all expressed high levels of FZD10 (P < 0.01). The exosomes derived from 95D and H1299 cells significantly enhanced tube formation ability and increased the expressions of VEGFA and Ang-1 protein and mRNA in HUVECs (P < 0.01), but FZD10 knockdown in 95D and H1299 cells obviously inhibited these effects of the exosomes. Exosomal FZD10 knockdown suppressed the activation of PI3K and Erk1/2 signaling pathways, but had no obvious effect on the activation of YAP/TAZ signaling pathway.

Conclusion: Exosomal FZD10 derived from NSCLC cells promotes HUVEC angiogenesis in vitro, the mechanism of which may involve the activation of PI3K and Erk1/2 signaling pathways.

目的: 探讨非小细胞肺癌(NSCLC)细胞外泌体源性FZD10在血管生成中的作用及其机制。

方法: 采用超速离心法分离外泌体,并利用Western blot和RT-qPCR技术分析NSCLC细胞(95D和H1299)、正常人支气管上皮细胞(BEAS-2B)及其外泌体中FZD10的表达;通过转染FZD10-siRNA敲低FZD10表达,用FZD10未敲低和敲低的NSCLC细胞外泌体分别处理HUVEC细胞,利用体外血管生成实验观察其成管能力,采用ELISA和RT-qPCR技术分析血管生成相关因子VEGFA和Ang-1的表达;进一步利用Western blot分析外泌体源性FZD10对信号通路PI3K、Erk1/2和YAP/TAZ激活的影响。

结果: 同BEAS-2B细胞及其外泌体相比较,FZD10在95D和H1299细胞及其外泌体中高表达(P < 0.01);95D和H1299细胞来源的外泌体可促进HUVEC的微管形成及VEGFA、Ang-1的蛋白分泌、mRNA的表达(P < 0.01),但在95D和H1299细胞敲低FZD10后这些效果受到抑制。FZD10的敲低可抑制PI3K、Erk1/2信号通路的激活,但对YAP/TAZ信号通路的影响不显著。

结论: NSCLC细胞外泌体源性FZD10可促进体外血管生成,其机制可能与PI3K、Erk1/2信号通路的激活有关。

Keywords: FZD10; angiogenesis; exosomes; non-small cell lung cancer.

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / metabolism
  • Cell Proliferation
  • Culture Media, Conditioned
  • Exosomes*
  • Frizzled Receptors / metabolism
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Lung Neoplasms* / metabolism
  • MicroRNAs* / genetics
  • Neovascularization, Pathologic / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • RNA, Messenger / metabolism
  • RNA, Small Interfering / metabolism

Substances

  • Culture Media, Conditioned
  • FZD10 protein, human
  • Frizzled Receptors
  • MicroRNAs
  • RNA, Messenger
  • RNA, Small Interfering

Grants and funding

国家自然科学基金(81372511); 广东省基础与应用基础研究基金(2019A1515011081); 广东省“扬帆计划”培养高层次人才项目(201635011); 广东省普通高校特色创新类项目(自然科学) (2022KTSCX048)